In addition, genetic aberrations in cancer cells can result in the downregulation of pro-apoptotic genes (e.g., p53, BAX, PTEN) or the upregulation of genes related to cell survival (e.g., PI3K, BCL-2) (Huang et al., 2022). This evidence concerns the gene TP53 and cancer.